<dl class="row">
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sud D, Laughton E, McAskill R, Bradley E, Maidment I. The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review. Syst Rev. 2021 Mar 31;10(1):92. doi: 10.1186/s13643-021-01586-9. PMID: 33789745; PMCID: PMC8015120. 
  </ref>
  <a><pmid>PMID33789745   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Eshiet UI, Okonta JM, Ukwe CV. Impact of a pharmacist-led education and counseling interventions on quality of life in epilepsy: A randomized controlled trial. Epilepsy Res. 2021 Aug;174:106648. doi: 10.1016/j.eplepsyres.2021.106648. Epub 2021 Apr 27. PMID: 33945920. 
  </ref>
  <a><pmid>PMID33945920   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chaudhary S, Ray R, Glass B. Pharmacists' role in transgender healthcare: A scoping review. Res Social Adm Pharm. 2021 Sep;17(9):1553-1561. doi: 10.1016/j.sapharm.2020.12.015. Epub 2021 Jan 2. PMID: 33436315. 
  </ref>
  <a><pmid>PMID33436315   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Salazar-Ospina A, Amariles P, Hincapié-García JA, González-Avendaño S. Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study. Heliyon. 2020;6(2):e03333. Published 2020 Feb 11. doi:10.1016/j.heliyon.2020.e03333 
  </ref>
  <a><pmid>PMID32072044   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Davis B, Qian J, Ngorsuraches S, Jeminiwa R, Garza KB. The clinical impact of pharmacist services on mental health collaborative teams: A systematic review. J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5S):S44-S53. doi: 10.1016/j.japh.2020.05.006. Epub 2020 Jun 27. PMID: 32600986; PMCID: PMC7529835. 
  </ref>
  <a><pmid>PMID32600986   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bingham J, Silva-Almodóvar A, Lee H, Benson C, Michael R, Azurin CM, Taylor AM. The role of the pharmacist in mental health: An investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes. J Am Pharm Assoc (2003). 2020 Jul-Aug;60(4):e58-e63. doi: 10.1016/j.japh.2020.01.009. Epub 2020 Feb 26. PMID: 32113946. 
  </ref>
  <a><pmid>PMID32113946   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pouplin M, Caty-Villa C, Meriglier L, Egron A, Parneix-Sediey L. Coordination des activités de pharmacie clinique dans une unité de psychiatrie adulte : impact clinique et médicoéconomique des interventions pharmaceutiques [Clinical pharmacy activities coordination in an adult psychiatry unit: Clinical and medicoeconomic impact of pharmaceutical interventions]. Ann Pharm Fr. 2020 Sep;78(5):415-425. French. doi: 10.1016/j.pharma.2020.04.003. Epub 2020 May 8. PMID: 32437641. 
  </ref>
  <a><pmid>PMID32437641   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Watkins VA, Michaels NM, Jackson DL, Rhodes LA, Marciniak MW. The effect of community pharmacist-led health coaching on clinical outcomes. J Am Pharm Assoc (2003). 2020 May-Jun;60(3S):S65-S69. doi: 10.1016/j.japh.2020.03.021. Epub 2020 May 18. PMID: 32439280. 
  </ref>
  <a><pmid>PMID32439280   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Werremeyer A, Bostwick J, Cobb C, et al. Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Ment Health Clin. 2020;10(6):358-380. Published 2020 Nov 5. doi:10.9740/mhc.2020.11.358 
  </ref>
  <a><pmid>PMID33224694   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rainey CA, Palmer MC. Impact of the addition of a clinical pharmacist to a community hospital psychiatric consult liaison team. Ment Health Clin. 2020;10(5):301-304. Published 2020 Sep 30. doi:10.9740/mhc.2020.09.301 
  </ref>
  <a><pmid>PMID33062557   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     AlRuthia Y, Alkofide H, Alosaimi FD, et al. Drug-drug interactions and pharmacists' interventions among psychiatric patients in outpatient clinics of a teaching hospital in Saudi Arabia. Saudi Pharm J. 2019;27(6):798‐802. doi:10.1016/j.jsps.2019.05.001 
  </ref>
  <a><pmid>PMID31516322   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nguyen TA, Gilmartin-Thomas J, Tan ECK, et al. The Impact of Pharmacist Interventions on Quality Use of Medicines, Quality of Life, and Health Outcomes in People with Dementia and/or Cognitive Impairment: A Systematic Review. J Alzheimers Dis. 2019;71(1):83-96. doi:10.3233/JAD-190162 
  </ref>
  <a><pmid>PMID31356204   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stuhec M, Bratović N, Mrhar A. Impact of clinical pharmacist's interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomized study. Sci Rep. 2019;9(1):16856. Published 2019 Nov 14. doi:10.1038/s41598-019-53057-w 
  </ref>
  <a><pmid>PMID31728029   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tillman F 3rd, Greenberg J, Liu I, Khalid S, McGuire N, Harris SC. Assessment of pharmacy-driven transitional interventions in hospitalized patients with psychiatric disorders. J Am Pharm Assoc (2003). 2020;60(1):22-30. doi:10.1016/j.japh.2019.09.024 
  </ref>
  <a><pmid>PMID31859220   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Riou S, Rose F-X, Maillard C, Blanc-Lobreneaux O. Évaluation de la pertinence des interventions pharmaceutiques en santé mentale avec deux méthodes complémentaires : l’échelle CLEO et la méthode des number needed to treat (NNT) et number needed to harm (NNH). Pharm Hosp Clin. 2019;54:272-278. 
  </ref>
  <a><pmid>LID282   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yalçin N, Ak S, Gürel ŞC, Çeliker A. Compliance in schizophrenia spectrum disorders: the role of clinical pharmacist. Int Clin Psychopharmacol. 2019;34(6):298-304. doi:10.1097/YIC.0000000000000280 
  </ref>
  <a><pmid>PMID31343497   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bingham J, Axon DR, Scovis N, Taylor AM. Evaluating the Effectiveness of
Clinical Pharmacy Consultations on Nutrition, Physical Activity, and Sleep in
Improving Patient-Reported Psychiatric Outcomes for Individuals with Mental
Illnesses. Pharmacy (Basel). 2018 Dec 22;7(1). pii: E2. doi:
10.3390/pharmacy7010002. 
  </ref>
  <a><pmid>PMID30583547   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Perepelkin J, Antunes K, Boechler L, Remillard AJ, Mildenberger L. Providing
mindfulness meditation for patients with depression and anxiety in a community
pharmacy: A pilot study. J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2):258-264.
doi: 10.1016/j.japh.2018.10.017. Epub 2018 Dec 11. 
  </ref>
  <a><pmid>PMID30552050   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Maryan S, Harms M, McAllister E, DeJongh B. Comparison of clozapine monitoring
and adverse event management in a psychiatrist-only and a clinical
pharmacist-psychiatrist collaborative clinic. Ment Health Clin. 2019 Mar
1;9(2):70-75. doi: 10.9740/mhc.2019.03.070. eCollection 2019 Mar. 
  </ref>
  <a><pmid>PMID30842913   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chavez B, Kosirog E. Impact on an integrated psychiatric pharmacy service in a primary care clinic. Ment Health Clin. 2019;9(4):269‐274. Published 2019 Jul 1. doi:10.9740/mhc.2019.07.269 
  </ref>
  <a><pmid>PMID31293846   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mishra A, Krishna GS, Alla S, Kurian TD, Kurian J, Ramesh M, Kishor M. Impact of Pharmacist-Psychiatrist Collaborative Patient Education on Medication
Adherence and Quality of Life (QOL) of Bipolar Affective Disorder (BPAD)
Patients. Front Pharmacol. 2017 Oct 10;8:722. doi: 10.3389/fphar.2017.00722.
eCollection 2017. 
  </ref>
  <a><pmid>PMID29066976   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Herbert C, Winkler H. Impact of a clinical pharmacist-managed clinic in
primary care mental health integration at a Veterans Affairs health system. Ment Health Clin. 2018 Apr 26;8(3):105-109. doi: 10.9740/mhc.2018.05.105. eCollection 2018 May. 
  </ref>
  <a><pmid>PMID29955554   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Luchen GG, Prohaska ES, Ruisinger JF, Melton BL. Impact of community
pharmacist intervention on concurrent benzodiazepine and opioid prescribing
patterns. J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2):238-242. doi:
10.1016/j.japh.2018.10.010. Epub 2018 Dec 11. 
  </ref>
  <a><pmid>PMID30552053   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cotugno S, Morrow G, Cooper C, Cabie M, Cohn S. Impact of pharmacist intervention on influenza vaccine assessment and documentation in hospitalized psychiatric patients. Am J Health Syst Pharm. 2017;74(23 Supplement 4):S90‐S94. doi:10.2146/ajhp160755 
  </ref>
  <a><pmid>PMID29167145   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tang SS, Jaward L, Ward K, Parikh SV, Bostwick JR. Impact of a Student
Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study. Psychopharmacol Bull. 2017 May
15;47(2):36-41. 
  </ref>
  <a><pmid>PMID28626270   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Elkhodr S, Saba M, O'Reilly C, Saini B. The role of community pharmacists in
the identification and ongoing management of women at risk for perinatal
depression: A qualitative study. Int J Soc Psychiatry. 2018 Feb;64(1):37-48. doi:
10.1177/0020764017746198. Epub 2017 Dec 8. 
  </ref>
  <a><pmid>PMID29219031   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Maidment ID, Aston L, Moutela T, Fox CG, Hilton A. A qualitative study
exploring medication management in people with dementia living in the community
and the potential role of the community pharmacist. Health Expect. 2017
Oct;20(5):929-942. doi: 10.1111/hex.12534. Epub 2017 Jan 19. 
  </ref>
  <a><pmid>PMID28105781   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Giannetti V, Caley CF, Kamal KM, Covvey JR, McKee J, Wells BG, Najarian DM,
Dunn TJ, Vadagam P. Community pharmacists and mental illness: a survey of service
provision, stigma, attitudes and beliefs. Int J Clin Pharm. 2018
Oct;40(5):1096-1105. doi: 10.1007/s11096-018-0619-7. Epub 2018 Jun 4. 
  </ref>
  <a><pmid>PMID29862460   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kassie GM, Kalisch Ellett LM, Nguyen TA, Roughead EE. Current practice and
opinions of hospital pharmacists regarding their role in the screening,
prevention and treatment of delirium. Int J Clin Pharm. 2017 Dec;39(6):1194-1200.
doi: 10.1007/s11096-017-0547-y. Epub 2017 Oct 16. 
  </ref>
  <a><pmid>PMID29038936   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hammad EA, Qudah RA, Akour AA. The impact of clinical pharmacists in improving
Jordanian patients' health outcomes. Saudi Med J. 2017 Nov;38(11):1077-1089. doi:
10.15537/smj.2017.11.21453. Review. 
  </ref>
  <a><pmid>PMID29114694   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Murphy AL, Martin-Misener R, Kutcher SP, Gardner DM. Pharmacists' performance in a telephone-based simulated patient study after a mental health
capacity-building program. Int J Clin Pharm. 2015 Dec;37(6):1009-13. doi:
10.1007/s11096-015-0171-7. Epub 2015 Jul 26. 
  </ref>
  <a><pmid>PMID26210258   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Deslandes RE, John DN, Deslandes PN. An exploratory study of the patient experience of pharmacist supplementary prescribing in a secondary care mental health setting. Pharm Pract (Granada). 2015 Apr-Jun;13(2):553. Epub 2015 Jun 15. PubMed PMID: 26131043; PubMed Central PMCID: PMC4482843. 
  </ref>
  <a><pmid>PMID26131043   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mohammed MA, Moles RJ, Chen TF. Impact of Pharmaceutical Care Interventions on
Health-Related Quality-of-Life Outcomes: A Systematic Review and Meta-analysis.
Ann Pharmacother. 2016 Oct;50(10):862-81. doi: 10.1177/1060028016656016. Review. 
  </ref>
  <a><pmid>PMID27363846   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wongpakaran R, Suansanae T, Tan-Khum T, Kraivichian C, Ongarjsakulman R,
Suthisisang C. Impact of providing psychiatry specialty pharmacist intervention
on reducing drug-related problems among children with autism spectrum disorder
related to disruptive behavioural symptoms: A prospective randomized open-label
study. J Clin Pharm Ther. 2017 Jun;42(3):329-336. doi: 10.1111/jcpt.12518. Epub
2017 Mar 20. 
  </ref>
  <a><pmid>PMID28317138   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Skoy ET, Eukel HN, Frenzel JE, Werremeyer A, McDaniel B. Use of an Auditory
Hallucination Simulation to Increase Student Pharmacist Empathy for Patients with
Mental Illness. Am J Pharm Educ. 2016 Oct 25;80(8):142. 
  </ref>
  <a><pmid>PMID27899838   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ní Dhubhlaing C, Young A, Sahm LJ. Impact of Pharmacist Counselling on
Clozapine Knowledge. Schizophr Res Treatment. 2017;2017:6120970. doi:
10.1155/2017/6120970. Epub 2017 Jun 13. 
  </ref>
  <a><pmid>PMID28695011   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Harms M, Haas M, Larew J, DeJongh B. Impact of a mental health clinical
pharmacist on a primary care mental health integration team. Ment Health Clin.
2018 Mar 23;7(3):101-105. doi: 10.9740/mhc.2017.05.101. eCollection 2017 May. 
  </ref>
  <a><pmid>PMID29955506   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Goedken AM, Butler CM, McDonough RP, Deninger MJ, Doucette WR. Continuous
Medication Monitoring (CoMM): A foundational model to support the clinical work
of community pharmacists. Res Social Adm Pharm. 2018 Jan;14(1):106-111. doi:
10.1016/j.sapharm.2016.12.008. Epub 2017 Jan 2. 
  </ref>
  <a><pmid>PMID28087207   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Matzke GR, Moczygemba LR, Williams KJ, Czar MJ, Lee WT. Impact of a
pharmacist-physician collaborative care model on patient outcomes and health
services utilization. Am J Health Syst Pharm. 2018 Jul 15;75(14):1039-1047. doi: 10.2146/ajhp170789. Epub 2018 May 22. 
  </ref>
  <a><pmid>PMID29789318   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Watson LC, Esserman DA, Ivey JL, Lewis CL, Hansen R, Weinberger M, Roth MT. Enhancing Quality in Psychiatry with Psychiatrists (EQUIPP)--results from a pilot study. Am J Geriatr Psychiatry. 2014 Sep;22(9):884-8. doi: 10.1016/j.jagp.2013.01.075. Epub 2013 Sep 8. PubMed PMID: 24021216; PubMed Central PMCID: PMC3864144. 
  </ref>
  <a><pmid>PMID24021216   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rubio-Valera M, Chen TF, O'Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014 Oct 21;11(10):10967-90. doi: 10.3390/ijerph111010967. PubMed PMID: 25337943; PubMed Central PMCID: PMC4211017. 
  </ref>
  <a><pmid>PMID25337943   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aljumah K, Hassali MA. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry. 2015 Sep 16;15:219. 
  </ref>
  <a><pmid>PMID26376830   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Selcuk A, Sancar M, Okuyan B, Demirtunc R, Izzettin FV. The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie.2015 Aug;70(8):559-62. PubMed PMID: 26380527. 
  </ref>
  <a><pmid>PMID26380527   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Macfarlane B, Bergin J, Peterson GM. Assessment and management of serotonin syndrome in a simulated patient study of Australian community pharmacies. Pharm Pract (Granada). 2016 Apr-Jun;14(2):703. doi: 10.18549/PharmPract.2016.02.703. Epub 2016 Jun 15. 
  </ref>
  <a><pmid>PMID27382424   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gardner KN, Diefenderfer LA, Nelson LA, Iuppa C, Elliott E, Kleinhesselink K, Sass D, Sommi RW. Cost-avoidance and qualitative analysis of clinical pharmacy
interventions by psychiatric pharmacy residents at state psychiatric facilities. Am J Health Syst Pharm. 2016 Jan 1;73(1):e46-53. doi: 10.2146/ajhp150368. 
  </ref>
  <a><pmid>PMID26683680   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bamgbade BA, Barner JC, Ford KH. Evaluating the Impact of an Anti-stigma
Intervention on Pharmacy Students' Willingness to Counsel People Living with
Mental Illness. Community Ment Health J. 2017 Jul;53(5):525-533. doi:
10.1007/s10597-016-0075-6. Epub 2016 Dec 15. 
  </ref>
  <a><pmid>PMID27981413   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McMillan SS, Kelly F, Hattingh HL, Fowler JL, Mihala G, Wheeler AJ. The impact
of a person-centred community pharmacy mental health medication support service
on consumer outcomes. J Ment Health. 2017 Jul 4:1-10. doi:
10.1080/09638237.2017.1340618. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID28675321   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wolf C, Pauly A, Mayr A, Grömer T, Lenz B, Kornhuber J, Friedland K.
Pharmacist-Led Medication Reviews to Identify and Collaboratively Resolve
Drug-Related Problems in Psychiatry - A Controlled, Clinical Trial. PLoS One.
2015 Nov 6;10(11):e0142011. doi: 10.1371/journal.pone.0142011. eCollection 2015. 
  </ref>
  <a><pmid>PMID26544202   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rubio-Valera M, March Pujol M, Fernández A, Peñarrubia-María MT, Travé P, López Del Hoyo Y, Serrano-Blanco A. Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: a randomized controlled superiority trial. Eur Neuropsychopharmacol. 2013 Sep;23(9):1057-66. doi: 10.1016/j.euroneuro.2012.11.006. Epub 2012 Dec 6. PubMed PMID: 23219937. 
  </ref>
  <a><pmid>PMID23219937   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bakhsh HT, Perona SJ, Shields WA, Salek S, Sanders AB, Patanwala AE. Medication errors in psychiatric patients boarded in the emergency department. Int J Risk Saf Med. 2014;26(4):191-8. doi: 10.3233/JRS-140634. PubMed PMID: 25420761. 
  </ref>
  <a><pmid>PMID25420761   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brownlie K, Schneider C, Culliford R, Fox C, Boukouvalas A, Willan C, Maidment
ID. Medication reconciliation by a pharmacy technician in a mental health
assessment unit. Int J Clin Pharm. 2014 Apr;36(2):303-9. 
  </ref>
  <a><pmid>PMID24234944   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Penm J, Li Y, Zhai S, Hu Y, Chaar B, Moles R. The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China's current healthcare reform. Health Policy Plan. 2014 Oct;29(7):849-872.Epub 2013 Sep 19. Review. PubMed PMID: 24056897 
  </ref>
  <a><pmid>PMID24056897   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Schneiderhan ME, Shuster SM, Davey CS. Twelve-month prospective randomized study of pharmacists utilizing point-of-care testing for metabolic syndrome and related conditions in subjects prescribed antipsychotics. Prim Care Companion CNS Disord. 2014 Oct 30;16(5). Doi: 10.4088/PCC.14m01669. eCollection 2014. PubMed PMID: 25667811; PubMed Central PMCID: PMC4321016 
  </ref>
  <a><pmid>PMID25667811   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Marques LA, Galduróz JC, Fernandes MR, Oliveira CC, Beijo LA, Noto AR. Assessment of the effectiveness of pharmacotherapy follow-up in patients treated  for depression. J Manag Care Pharm. 2013 Apr;19(3):218-27. PubMed PMID: 23537456. 
  </ref>
  <a><pmid>PMID23537456   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nazarian PK, Dopheide JA. Psychiatric pharmacist management of depression in patients with diabetes. Prim Care Companion CNS Disord. 2013;15(5). Pii: PCC.13l01543. doi: 10.4088/PCC.13l01543. PubMed PMID: 24511443; PubMed Central PMCID: PMC3907323. 
  </ref>
  <a><pmid>PMID24511443   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hashimoto Y, Tensho M. Effect of pharmacist intervention on physician
prescribing in patients with chronic schizophrenia: a descriptive pre/post study.
BMC Health Serv Res. 2016 Apr 26;16(1):150. doi: 10.1186/s12913-016-1408-4. 
  </ref>
  <a><pmid>PMID27117589   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Liekens S, Vandael E, Roter D, Larson S, Smits T, Laekeman G, Foulon V. Impact
of training on pharmacists' counseling of patients starting antidepressant
therapy. Patient Educ Couns. 2014 Jan;94(1):110-5. doi:
10.1016/j.pec.2013.09.023. Epub 2013 Oct 12. 
  </ref>
  <a><pmid>PMID24169022   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rubio-Valera M, Serrano-Blanco A, Magdalena-Belío J, Fernández A, García-Campayo J, Pujol MM, del Hoyo YL. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis. Ann Pharmacother. 2011 Jan;45(1):39-48. Epub 2011 Jan 4. Review. 
  </ref>
  <a><pmid>PMID21205952   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hashimoto Y, Tensho M. The need for educating patients with schizophrenia
about the adverse effects of medications. Australas Psychiatry. 2016 Feb 24. pii:
1039856216634825. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID26912469   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rubio-Valera M, Bosmans J, Fernández A, Peñarrubia-María M, March M, Travé P,  Bellón JA, Serrano-Blanco A. Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study). PLoS One. 2013 Aug 12;8(8):e70588. doi: 10.1371/journal.pone.0070588. eCollection 2013. PubMed PMID: 23950967; PubMed Central PMCID: PMC3741197. 
  </ref>
  <a><pmid>PMID23950967   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Iuppa CA, Nelson LA, Elliott E, Sommi RW. Adverse drug reactions: a retrospective review of hospitalized patients at a state psychiatric hospital. Hosp Pharm. 2013 Dec;48(11):931-5. doi: 10.1310/hpj4811-931. PubMed PMID: 24474834; PubMed Central PMCID: PMC3875105. 
  </ref>
  <a><pmid>PMID24474834   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al-Jumah KA, Qureshi NA. Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review. Patient Prefer Adherence. 2012;6:87-100. doi: 10.2147/PPA.S27436. 
  </ref>
  <a><pmid>PMID22346345   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wang I, Dopheide JA, Gregerson P. Role of a psychiatric pharmacist in a Los Angeles "Skid-Row" safety-net clinic. J Urban Health. 2011 Aug;88(4):718-23. doi: 10.1007/s11524-011-9573-6. 
  </ref>
  <a><pmid>PMID21512832   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lerat MC, Cabelguenne D, Lassia J, Meunier F, Zimmer L. Impact of pharmacist and clinician dual intervention on prescribed benzodiazepines in prisoner patients: a retrospective study. Fundam Clin Pharmacol. 2011 Dec;25(6):762-7.doi: 10.1111/j.1472-8206.2010.00902.x. Epub 2010 Dec 20 
  </ref>
  <a><pmid>PMID21166860   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bichard D, Gaillard C, Bourscheid S et al. Impact d’une réunion de concertation pluridisciplinaire (RCP) sur le risque potentiel d’événement indésirable médicamenteux dans une unité d’admission de psychogériatrie Pharm Hosp 2012;47 :166-76. 
  </ref>
  <a><pmid>LID174   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Foppe van Mil JW. Le pharmacien d’officine et la pathologie psychiatrique, une revue. Pharm Hosp. 2010;45 :79-84. 
  </ref>
  <a><pmid>LID190   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kjeldsen LJ, Hansen PS, Kristensen AM, Christensen A, Sørensen CH, Nielsen B.  Outreach visits by clinical pharmacists improve screening for the metabolic syndrome among mentally ill patients. Nord J Psychiatry. 2013 Aug;67(4):249-57. doi: 10.3109/08039488.2012.732115. Epub 2012 Nov 6. PubMed PMID: 23126478. 
  </ref>
  <a><pmid>PMID23126478   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Phimarn W, Kaewphila P, Suttajit S, Saramunee K. Depression screening and advisory service provided by community pharmacist for depressive students inuniversity. Springerplus. 2015 Sep 2;4:470. doi: 10.1186/s40064-015-1259-1.eCollection 2015. PubMed PMID:26357601; PubMed Central PMCID: PMC4556723 
  </ref>
  <a><pmid>PMID26357601   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Patel B, Afghan S. Effects of an educational outreach campaign (IMPACT) on depression management delivered to general practitioners in one primary care trust. Ment Health Fam Med. 2009 Sep;6(3):155-62. 
  </ref>
  <a><pmid>PMID22477906   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chung B, Dopheide JA, Gregerson P. Psychiatric pharmacist and primary care collaboration at a skid-row safety-net clinic. J Natl Med Assoc. 2011 Jul;103(7):567-74. 
  </ref>
  <a><pmid>PMID21999031   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Roth MT, Watson LC, Esserman DA, Ivey JL, Hansen R, Lewis CL, Weinberger M. Methodology of a pilot study to improve the quality of medication use in older adults: Enhancing Quality in Psychiatry Using Pharmacists (EQUIPP). Am J Geriatr Pharmacother. 2009 Dec;7(6):362-72. doi: 10.1016/j.amjopharm.2009.11.007. 
  </ref>
  <a><pmid>PMID20129257   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wheeler A, Crump K, Lee M, Li L, Patel A, Yang R, Zhao J, Jensen M. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health. Res Social Adm Pharm. 2012 May-Jun;8(3):179-92. 
  </ref>
  <a><pmid>PMID21831724   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bedouch P, Sylvoz N, Charpiat B, Juste M, Roubille R, Rose FX, Bosson JL, Conort O, Allenet B; French Society of Clinical Pharmacy's Act-IP© Group. Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP© website observatory. J Clin Pharm Ther. 2015 Feb;40(1):32-40. doi: 10.1111/jcpt.12214. Epub 2014 Oct 10. PubMed PMID: 25303720. 
  </ref>
  <a><pmid>PMID25303720   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Black E, Murphy AL, Gardner DM. Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatr Serv. 2009 Aug;60(8):1123-7. doi: 10.1176/appi.ps.60.8.1123. 
  </ref>
  <a><pmid>PMID19648202   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pyne JM, Fortney JC, Curran GM, Tripathi S, Atkinson JH, Kilbourne AM,
Hagedorn HJ, Rimland D, Rodriguez-Barradas MC, Monson T, Bottonari KA, Asch SM,
Gifford AL. Effectiveness of collaborative care for depression in human
immunodeficiency virus clinics. Arch Intern Med. 2011 Jan 10;171(1):23-31. doi:
10.1001/archinternmed.2010.395. 
  </ref>
  <a><pmid>PMID21220657   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm. 2007 Apr 15;64(8):842-9. 
  </ref>
  <a><pmid>PMID17420201   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Finley PR, Bluml BM, Bunting BA, Kiser SN. Clinical and economic outcomes of a pilot project examining pharmacist-focused collaborative care treatment for depression. J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):40-9. 
  </ref>
  <a><pmid>PMID21247825   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ito T, Shimizu K, Ichida Y, Ishibashi Y, Akizuki N, Ogawa A, Fujimori M, Kaneko N, Ueda I, Nakayama K, Uchitomi Y. Usefulness of pharmacist-assisted screening and psychiatric referral program for outpatients with cancer undergoing chemotherapy. Psychooncology. 2011 Jun;20(6):647-54. 
  </ref>
  <a><pmid>PMID21384467   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Crockett J, Taylor S, Grabham A, Stanford P. Patient outcomes following an intervention involving community pharmacists in the management of depression. Aust J Rural Health. 2006 Dec;14(6):263-9. 
  </ref>
  <a><pmid>PMID17121506   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Suehs BT, Mican LM, Campbell AH. Retrospective evaluation of an inpatient psychiatric pharmacist consultation service. J Am Pharm Assoc (2003). 2011 Sep-Oct;51(5):599-604. doi: 10.1331/JAPhA.2011.10107. 
  </ref>
  <a><pmid>PMID21896457   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Caballero J, Souffrant G, Heffernan E. Development and outcomes of a psychiatric pharmacy clinic for indigent patients. Am J Health Syst Pharm. 2008 Feb 1;65(3):229-33. doi: 10.2146/ajhp070266. 
  </ref>
  <a><pmid>PMID18216008   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Using a pharmacy-based intervention to improve antipsychotic adherence among  patients with serious mental illness. Schizophr Bull. 2011 Jul;37(4):727-36. doi: 10.1093/schbul/sbp121. Epub 2009 Nov 21. 
  </ref>
  <a><pmid>PMID19933540   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG, Katon
WJ, Sullivan SD. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm. 2004 Feb 15;61(4):364-72. 
  </ref>
  <a><pmid>PMID15011764   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pyne JM, Fortney JC, Tripathi SP, Maciejewski ML, Edlund MJ, Williams DK. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. Arch Gen Psychiatry. 2010 Aug;67(8):812-21. 
  </ref>
  <a><pmid>PMID20679589   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stubbs J, Haw C, Taylor D. Prescription errors in psychiatry - a multi-centre study. J Psychopharmacol. 2006 Jul;20(4):553-61. Epub 2006 Jan 9. 
  </ref>
  <a><pmid>PMID16401663   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Monette J, Champoux N, Monette M, Fournier L, Wolfson C, du Fort GG, Sourial N, Le Cruguel JP, Gore B. Effect of an interdisciplinary educational program on antipsychotic prescribing among nursing home residents with dementia. Int J Geriatr Psychiatry. 2008 Jun;23(6):574-9. 
  </ref>
  <a><pmid>PMID17968860   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 2003 Sep;23(9):1175-85. 
  </ref>
  <a><pmid>PMID14524649   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003 Dec;23(12):1634-44. Review. 
  </ref>
  <a><pmid>PMID14695043   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF. Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses. Clin Drug Investig. 2006;26(7):415-25. 
  </ref>
  <a><pmid>PMID17163274   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. J Am Pharm Assoc (2003). 2005 May-Jun;45(3):344-53. 
  </ref>
  <a><pmid>PMID15991756   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bosmans JE, Brook OH, van Hout HP, de Bruijne MC, Nieuwenhuyse H, Bouter LM, Stalman WA, van Tulder MW. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants. Pharmacoeconomics. 2007;25(1):25-37. 
  </ref>
  <a><pmid>PMID17192116   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Improving patient feedback about and outcomes with antidepressant treatment: a study in
eight community pharmacies. J Am Pharm Assoc (2003). 2006 Jan-Feb;46(1):25-32. 
  </ref>
  <a><pmid>PMID16529338   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Duvauchelle B, Pons D, Lernout P, Compagnon M. Mise en place et première évaluation de recommandations de surveillance de l'espace QT lors de la prescription de neuroleptiques. Pharm Hosp. 2006;40 :7-12. 
  </ref>
  <a><pmid>LID198   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brook OH, Van Hout HP, Nieuwenhuysea H, De Haan M. Effects of coaching by community pharmacists on psychological symptoms of antidepressant users; a randomised controlled trial. Eur Neuropsychopharmacol. 2003 Oct;13(5):347-54. 
  </ref>
  <a><pmid>PMID12957333   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brook O, van Hout H, Nieuwenhuyse H, Heerdink E. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol. 2003 Jan;13(1):1-9. 
  </ref>
  <a><pmid>PMID12480116   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Furniss L, Burns A, Craig SK, Scobie S, Cooke J, Faragher B. Effects of a pharmacist's medication review in nursing homes : Randomised controlled trial. Br J Psychiatry. 2000 Jun;176:563-7. 
  </ref>
  <a><pmid>PMID10974963   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brook OH, van Hout H, Stalman W, Nieuwenhuyse H, Bakker B, Heerdink E, de Haan M. A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatr Serv. 2005 Apr;56(4):487-9. 
  </ref>
  <a><pmid>PMID15812103   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Adler DA, Bungay KM, Wilson IB, Pei Y, Supran S, Peckham E, Cynn DJ, Rogers WH. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004 May-Jun;26(3):199-209. 
  </ref>
  <a><pmid>PMID15121348   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bungay KM, Adler DA, Rogers WH, McCoy C, Kaszuba M, Supran S, Pei Y, Cynn DJ, Wilson IB. Description of a clinical pharmacist intervention administered to primary care patients with depression. Gen Hosp Psychiatry. 2004 May-Jun;26(3):210-8. 
  </ref>
  <a><pmid>PMID15121349   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1999 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stoner SC, Worrel JA, Jones MT, Farrar CA, Ramlatchman LV. Pharmacist-designed and -implemented pharmaceutical care plan for antipsychotic-induced movement disorders. Pharmacotherapy. 2000 May;20(5):583-8. 
  </ref>
  <a><pmid>PMID10809346   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002 Aug 15;59(16):1518-26. 
  </ref>
  <a><pmid>PMID12185826   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1997 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm. 2001 Jul 15;58(14):1309-16. 
  </ref>
  <a><pmid>PMID11471478   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1997 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Alderman CP. A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unit. J Clin Pharm Ther. 1997 Feb;22(1):27-31. 
  </ref>
  <a><pmid>PMID9292399   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):36-43. 
  </ref>
  <a><pmid>PMID11833513   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dorevitch A, Perl E. The impact of clinical pharmacy intervention in a psychiatric hospital. J Clin Pharm Ther. 1996 Feb;21(1):45-8. 
  </ref>
  <a><pmid>PMID8737183   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1995 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jenkins MH, Bond CA. The impact of clinical pharmacists on psychiatric patients. Pharmacotherapy. 1996 Jul-Aug;16(4):708-14. Review. 
  </ref>
  <a><pmid>PMID8840383   </pmid></a> 
</dd> 
</dl>